These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 31253089)

  • 1. In silico analysis of missense mutations in exons 1-5 of the F9 gene that cause hemophilia B.
    Meléndez-Aranda L; Jaloma-Cruz AR; Pastor N; Romero-Prado MMJ
    BMC Bioinformatics; 2019 Jun; 20(1):363. PubMed ID: 31253089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new in silico approach to investigate molecular aspects of factor IX missense causative mutations and their impact on the hemophilia B severity.
    Meireles MR; Bragatte MAS; Bandinelli E; Salzano FM; Vieira GF
    Hum Mutat; 2019 Jun; 40(6):706-715. PubMed ID: 30817849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico profiling of deleterious amino acid substitutions of potential pathological importance in haemophlia A and haemophlia B.
    Doss C GP
    J Biomed Sci; 2012 Mar; 19(1):30. PubMed ID: 22423892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B.
    Radic CP; Rossetti LC; Abelleyro MM; Candela M; Pérez Bianco R; de Tezanos Pinto M; Larripa IB; Goodeve A; De Brasi C
    Thromb Haemost; 2013 Jan; 109(1):24-33. PubMed ID: 23093250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation Spectrum and Genotype-Phenotype Analyses in a Pakistani Cohort With Hemophilia B.
    Khan MTM; Naz A; Ahmed J; Shamsi T; Ahmed S; Ahmed N; Imran A; Farooq N; Khan MTH; Taj AS
    Clin Appl Thromb Hemost; 2018 Jul; 24(5):741-748. PubMed ID: 28752769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel missense mutation in F9 gene causes hemophilia B in a family with clinical variability.
    Yi S; Yang Q; Zuo Y; Li M; Luo J; Qin Z; Zhang Q; Li M; Huang L; Lu Y; Feng S; Fan X
    Blood Coagul Fibrinolysis; 2020 Mar; 31(2):121-126. PubMed ID: 31904612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double mutation, a 2-bp deletion and Val211Ile, in the blood coagulation factor IX gene of a patient with severe hemophilia B].
    Seita I; Shinozawa K; Otaki M; Fujita S; Suzuki T; Amano K; Inaba H; Fukutake K
    Rinsho Byori; 2009 May; 57(5):417-24. PubMed ID: 19522246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analysis of phenotypes and genetics in 21 Chinese families with haemophilia B: characterization of five novel mutations.
    Guo ZP; Yang LH; Qin XY; Liu XE; Chen JF; Zhang YF
    Haemophilia; 2014 Nov; 20(6):859-65. PubMed ID: 25251685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent synonymous mutation F9 c.87A>G causes secretion failure by in-frame mutation with aberrant splicing.
    Odaira K; Tamura S; Suzuki N; Kakihara M; Hattori Y; Tokoro M; Suzuki S; Takagi A; Katsumi A; Hayakawa F; Okamoto S; Suzuki A; Kanematsu T; Matsushita T; Kojima T
    Thromb Res; 2019 Jul; 179():95-103. PubMed ID: 31102861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The characteristics and spectrum of F9 mutations in Chinese sporadic haemophilia B pedigrees.
    Lu Y; Wu X; Dai J; Ding Q; Wu W; Wang X
    Haemophilia; 2019 Mar; 25(2):316-323. PubMed ID: 30648777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Canadian "National Program for hemophilia mutation testing" database: a ten-year review.
    Rydz N; Leggo J; Tinlin S; James P; Lillicrap D
    Am J Hematol; 2013 Dec; 88(12):1030-4. PubMed ID: 23913812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into molecular changes of the FIX protein in a series of Italian patients with haemophilia B.
    Bicocchi MP; Pasino M; Rosano C; Molinari AC; Della Valle E; Lanza T; Bottini F; Acquila M
    Haemophilia; 2006 May; 12(3):263-70. PubMed ID: 16643212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of mutations in the F9 gene including exon deletion by multiplex ligation-dependent probe amplification in 33 unrelated Korean patients with haemophilia B.
    Kwon MJ; Yoo KY; Kim HJ; Kim SH
    Haemophilia; 2008 Sep; 14(5):1069-75. PubMed ID: 18624698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular analysis of 76 Chinese hemophilia B pedigrees and the identification of 10 novel mutations.
    Huang L; Li L; Lin S; Chen J; Li K; Fan D; Jin W; Li Y; Yang X; Xiong Y; Li F; Yang X; Li M; Li Q
    Mol Genet Genomic Med; 2020 Nov; 8(11):e1482. PubMed ID: 32875744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of hemophilia B in North Indian families: identification of novel and recurrent molecular events in the factor IX gene.
    Mahajan A; Chavali S; Kabra M; Chowdhury MR; Bharadwaj D
    Haematologica; 2004 Dec; 89(12):1498-503. PubMed ID: 15590401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioinformatics approach for the phenotype prediction of nonsynonymous single nucleotide polymorphisms in human cytochromes P450.
    Wang LL; Li Y; Zhou SF
    Drug Metab Dispos; 2009 May; 37(5):977-91. PubMed ID: 19204079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Molecular Basis of FIX Deficiency in Hemophilia B.
    Shen G; Gao M; Cao Q; Li W
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SVA retrotransposition in exon 6 of the coagulation factor IX gene causing severe hemophilia B.
    Nakamura Y; Murata M; Takagi Y; Kozuka T; Nakata Y; Hasebe R; Takagi A; Kitazawa J; Shima M; Kojima T
    Int J Hematol; 2015 Jul; 102(1):134-9. PubMed ID: 25739383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic determinants of immunogenicity to factor IX during the treatment of haemophilia B.
    Saini S; Hamasaki-Katagiri N; Pandey GS; Yanover C; Guelcher C; Simhadri VL; Dandekar S; Guerrera MF; Kimchi-Sarfaty C; Sauna ZE
    Haemophilia; 2015 Mar; 21(2):210-218. PubMed ID: 25470321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splicing dysregulation contributes to the pathogenicity of several F9 exonic point variants.
    Katneni UK; Liss A; Holcomb D; Katagiri NH; Hunt R; Bar H; Ismail A; Komar AA; Kimchi-Sarfaty C
    Mol Genet Genomic Med; 2019 Aug; 7(8):e840. PubMed ID: 31257730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.